Sign In
Buy HZNP
$116.30
+0 (+0%)
At Close: Jan 04, 2024
FTC Suing To Stop Amgen's $27.8 Billion Purchase Of Horizon Therapeutics
12:21pm, Tuesday, 16'th May 2023
The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.
FTC to challenge Amgen's $28 billion deal with Horizon Therapeutics: Report
12:08pm, Tuesday, 16'th May 2023
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the sharp decline of Horizon Therapeutics shares after a report surfaced that the FTC is planning to sue to block Amgen's $28 billion purc
Why Horizon Therapeutics Stock Is Crashing Today
11:14am, Tuesday, 16'th May 2023
Last December, Amgen and Horizon agreed to a $27.8 billion buyout agreement. This proposed deal is now in doubt following a report that the FTC plans on challenging the takeover in federal court.
FTC Poised to Block Amgen's $27.8 Billion Deal for Horizon Therapeutics
10:21am, Tuesday, 16'th May 2023
The FTC is preparing to seek an injunction in federal court that would prevent the deal from closing.
FTC to challenge Amgen's $27.8B acquisition of Horizon Therapeutics: report
10:02am, Tuesday, 16'th May 2023
Shares of Horizon Therapeutics tumbled on Tuesday following a report that the Federal Trade Commission (FTC) is preparing to block its $27.8 billion sale to Amgen. Per a Bloomberg report citing an un
HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today
09:36am, Tuesday, 16'th May 2023
Horizon Therapeutics (NASDAQ: HZNP ) stock is sinking 18% this morning. The Federal Trade Commission (FTC) is reportedly attempting to block the drug maker's proposed merger with Amgen (NASDAQ: AMGN )
Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
07:54am, Tuesday, 16'th May 2023
The deal is bid to strengthen Amgen's drug portfolio as it prepares to face several patent expirations for key treatments over the next decade.
Horizon Therapeutics Stock Plunges on Reports FTC Will Sue to Block Amgen Deal
07:04am, Tuesday, 16'th May 2023
Amgen reached an agreement to buy Horizon for $27.8 billion in December last year, and at the time said it expected the deal to be completed in the first half of 2023.
Horizon (HZNP) Q1 Earnings and Revenues Miss Estimates
01:41pm, Wednesday, 03'rd May 2023
Horizon Therapeutics (HZNP) reports lower-than-expected first-quarter 2023 results as it misses the Zacks Consensus Estimates for both revenues and earnings.
These Are the Top 10 Holdings of Avoro Capital Advisors
10:54pm, Monday, 17'th Apr 2023
Avoro Capital Advisors (formerly known as venBio Select Advisor) is a global life sciences investment firm that focuses on emerging biotechnology companies.
New Strong Buy Stocks for April 14th
08:24am, Friday, 14'th Apr 2023
ABNB, SIGA, DRQ, SWRAY and HZNP have been added to the Zacks Rank #1 (Strong Buy) List on April 14, 2023.
5 Diverse Medical Stocks to Buy for 2023 and Beyond
07:01pm, Thursday, 06'th Apr 2023
The top and bottom-line growth make these Zacks Medical stocks very attractive.
The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks
12:33pm, Friday, 24'th Mar 2023
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
These Are the Top 10 Holdings of George Soros
10:56pm, Monday, 20'th Mar 2023
George Soros is considered to be among the most successful investors of all time. He managed client money from 1969 to 2011 and his Quantum Fund gave an average annual return of 30% from 1970 to 2000.
3 Reasons Growth Investors Will Love Horizon Therapeutics (HZNP)
02:31pm, Friday, 17'th Mar 2023
Horizon Therapeutics (HZNP) possesses solid growth attributes, which could help it handily outperform the market.
